{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:35:12Z","timestamp":1762101312656},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1999,11,9]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            \u2014Release of growth hormone (GH), putatively through alterations in insulin growth factor-1 (IGF-1) levels, has been implicated to influence left ventricular (LV) myocardial structure and function. The objective of this study was to determine contributory mechanisms by which GH supplementation may influence LV function with the development of congestive heart failure (CHF).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            \u2014Pigs were assigned to the following groups: (1) chronic pacing at 240 bpm for 3 weeks (n=10), (2) chronic pacing and GH supplementation (200 \u03bcg \u00b7 kg\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 d\n            <jats:sup>\u22121<\/jats:sup>\n            , n=10), and (3) controls (n=8). GH treatment increased IGF-1 plasma levels by nearly 2.5-fold throughout the pacing protocol. In the untreated pacing CHF group, LV fractional shortening was reduced and peak wall stress increased. In the pacing CHF and GH groups, LV fractional shortening was higher and LV wall stress lower than untreated CHF values. Steady-state myocyte velocity of shortening was reduced with pacing CHF and was unchanged from CHF values with GH treatment. In the presence of 25 nmol\/L isoproterenol, the change in myocyte shortening velocity was reduced in the untreated CHF group and increased in the GH-treated group. LV sarcoplasmic reticulum Ca\n            <jats:sup>2+<\/jats:sup>\n            -ATPase abundance was reduced with pacing CHF but was normalized with GH treatment.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            \u2014Short-term GH supplementation improved LV pump function in pacing CHF as a result of favorable effects on LV remodeling and contractile processes. Thus, GH supplementation may serve as a novel therapeutic modality in developing CHF.\n          <\/jats:p>","DOI":"10.1161\/01.cir.100.19.2003","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:42:29Z","timestamp":1339461749000},"page":"2003-2009","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Effects of Growth Hormone Supplementation on Left Ventricular Morphology and Myocyte Function With the Development of Congestive Heart Failure"],"prefix":"10.1161","volume":"100","author":[{"given":"Ward V.","family":"Houck","sequence":"first","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia C.","family":"Pan","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B.","family":"Kribbs","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Clair","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"McDaniel","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Stephen","family":"Krombach","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Merritt","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Pirie","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie P.","family":"Iannini","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupak","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis G.","family":"Spinale","sequence":"additional","affiliation":[{"name":"From the Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and the Department of Cardiovascular and Metabolic Disease, Pfizer Central Research, Groton, Conn (L.C.P., C.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.2.262"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.79.2.227"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.72.1.8417847"},{"key":"e_1_3_2_4_2","first-page":"555","volume":"15","year":"1994","unstructured":"Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 1994;15:555\u2013573.","journal-title":"Rev"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603283341301"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-29"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.3.562"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.83.2.1991381"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.2.1735164"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.71.1.1606661"},{"key":"e_1_3_2_11_2","unstructured":"Gaasch WH Freeman GL. Functional properties of normal and failing hearts. In: McCall D Rahimtoola SH eds. Heart Failure. New York NY: Chapman & Hall; 1995:14\u201329."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.69.4.1934334"},{"key":"e_1_3_2_13_2","first-page":"31","volume":"5","year":"1994","unstructured":"Gerdes AM, Kellerman SE, Malec KB, Schocken DD. Transverse shape characteristics of cardiac myocytes from rats and humans. Cardioscience. 1994;5:31\u201336.","journal-title":"Cardioscience"},{"key":"e_1_3_2_14_2","first-page":"H308","volume":"261","year":"1991","unstructured":"Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol. 1991;261:H308\u2013H318.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.4.778"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2527\/1998.7692368x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.5.7683979"},{"key":"e_1_3_2_18_2","first-page":"H969","volume":"272","year":"1997","unstructured":"Eble DM, Walker JD, Mukherjee R, Samarel AM, Spinale FG. Myosin heavy chain synthesis is increased in a rabbit model of heart failure. Am J Physiol. 1997;272:H969\u2013H978.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1999.276.1.E143"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.8.2306"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114737"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.00820.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365519509075396"},{"key":"e_1_3_2_24_2","first-page":"211","volume":"29","year":"1996","unstructured":"Hu Y, Pete G, Walsh MF, Sowers J, Dunbar JC. Central IGF-1 decreases systemic blood pressure and increases blood flow in selective vascular beds. Horm Metab Res. 1996;29:211\u2013214.","journal-title":"Horm Metab Res"},{"key":"e_1_3_2_25_2","first-page":"1881","volume":"83","year":"1998","unstructured":"Sverrisdottir YB, Elam M, Herlitz H, Bengtsson BA, Johannsson G. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab. 1998;83:1881\u20131885.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.5.1169"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.2.H456"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11329-0"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.100.19.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T12:57:51Z","timestamp":1715518671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.100.19.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11,9]]},"references-count":28,"journal-issue":{"issue":"19","published-print":{"date-parts":[[1999,11,9]]}},"alternative-id":["10.1161\/01.CIR.100.19.2003"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.100.19.2003","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11,9]]},"assertion":[{"value":"1998-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-06-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}